References
- Bonadonna G, Valagussa P. The contribution of medicine to the primary treatment of breast cancer. Cancer Res 1988: 48(9): 2314–24 [Erratum. Cancer Res 1988: 48(16): 4716]
- Glick JH. Meeting highlights: adjuvant therapy for breast cancer. J Natl Cancer Inst 1988: 80(7): 471–5
- Love RR. Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects. J Clin Oncol 1989: 7(6): 803–15
- Pritchard KI. Current status of adjuvant endocrine therapy for resectable breast cancer. Semin Oncol 1987: 14(1): 23–33
- Early Breast Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer an overview of 61 randomized trials among 28,896 women. N Engl J Med 1988: 319(26): 1681–92
- Fisher B, Redmond C, Dimitrov NV, et al. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med 1989: 320(8): 473–8
- Fisher B, Redmond C, Fisher ER, et al. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 1988: 6(7): 1076–87
- Cheson B. Clinical trials: adjuvant therapy of breast cancer. Oncology 1989: 3(6): 70–5
- Henderson IC, Hayes DF, Gelman R. Dose-response In the treatment of breast cancer: a critical review. J Clin Oncol 1988: 6(9): 1501–15
- Fisher B, Redmond C, Wickerham DL, et al. Doxorubicin-containing regimens for the treatment of stage n breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience. J Clin Oncol 1989: 7(5): 572–82
- ‘Nolvadex’ Adjuvant Trial Organisation. Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. Br J Cancer 1988: 57(6): 608–11
- Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC), Edinburgh. Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Lancet 1987: 2(8552): 171–5
- Fisher B, Brown A, Wolmark N, et al. Prolonging tamoxifen therapy for primary breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial. Ann Intern Med 1987: 106(5): 649–54
- Flsher B, Costantino J, Redmond C, et al. A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989: 320(8): 479–84
- Wittliff JL. Steroid-hormone receptors in breast cancer. Cancer 1984: 53(3 Suppl): 630–43
- Fisher B, Saffer EA, Deutsch M. Influence of irradiation of a primary tumor on the labeling Index and estrogen receptor index in a distant tumor focus. Int J Radiat Oncol Biol Phys 1986: 12(6): 879–85